Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
VIN 2
Hangzhou
VIN 2 Clinical Trials in Hangzhou
1 recruiting
Hangzhou, China
Showing
1–1
of
1
trials
Recruiting
Phase 3
Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years
Cervical Cancer
Vaginal Cancer
Vulvar Cancer
+12 more
Shanghai Bovax Biotechnology Co., Ltd.
1,200 enrolled
1 location
NCT04895020
Feedback